Other languages Malin Corporation plc

Equities

Market Closed - Irish S.E. Other stock markets 11:55:00 2024-05-31 am EDT			5-day change	1st Jan Change
5.7 ^EUR	-.--%		-3.39%	+26.67%

May. 01	Malin Corp investee signs agreement with Astellas Pharma	AN
Mar. 28	Transcript : Malin Corporation plc - Shareholder/Analyst Call

Malin Corp investee signs agreement with Astellas Pharma	May. 01
Malin : > Malin Corporation plc 2023 Information Statements	Apr. 10
Malin : > Malin Corporation plc 2023 Information Statements - Cover Letter	Apr. 10
Transcript : Malin Corporation plc - Shareholder/Analyst Call	Mar. 28
EARNINGS: Hutchmed revenue surges, Craven House's loss widens	Feb. 28
Tranche Update on Malin Corporation plc's Equity Buyback Plan announced on November 15, 2023.	Feb. 28
Puma and Puma Alpha invest in Not Another Beer	Jan. 26
Malin Corporation plc commences an Equity Buyback Plan, under the authorization approved on March 10, 2023.	Nov. 15
Malin confirms new executive director joins board	23-10-27
Malin Corporation plc Announces Board Changes	23-10-27
BiVictriX Therapeutics Appoints New CFO, Chief Business Officer	23-10-03
Malin Corporation plc Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-06
Solid State sees strong orders in security & defence	23-09-06
CG Oncology, Inc. announced that it has received $105 million in funding from a group of investors	23-08-01
CG Oncology, Inc. announced that it expects to receive $105.019993 million in funding	23-07-26
Malin CEO Darragh Lyons to resign before end of the year	23-07-05
Malin CEO to Step Down at 2023-end	23-07-05
Malin Corporation plc Announces CEO Changes	23-07-05
Malin Corporation plc Announces Executive Changes	23-07-05
Malin : Kymab successor company, Sanofi, announces positive topline Phase 2b data in atopic dermatitis for amlitelimab (KY1005)	23-06-27

No results for this search